Proteomics International just skyrocketed 50% after landing a landmark three-year distribution deal with Healius, giving their diagnostic tests for diabetic kidney disease and endometriosis nationwide access through Healius’ 2,000+ collection centers. This first-ever national partnership lets Proteomics focus on lab testing while Healius handles specimen collection and provider outreach, accelerating market reach without building infrastructure from scratch. CEO David Morris calls it a scalable path to turn research into revenue, with phased rollout expected later this year. The move aligns with their distributor-focused strategy and recent US patent win for their endometriosis test—signaling a major pivot toward consistent income generation.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
